Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
PureTech Health PLC
PRTCCurrent price
17.35 USD
+0.31 USD (+1.81%)
Last closed
16.72 USD
Company
www.puretechhealth.com
ISIN
US7462371060
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
421 531 680 USD
Yield for 12 month
-39.51 %
1Y
3Y
5Y
10Y
15Y
PRTC
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. Address: 6 Tide Street, Boston, MA, United States, 02210
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
53.25 USDP/E ratio
8.36Dividend Yield
–Current Year
+4 315 000 USD
Last Year
+3 330 000 USD
Current Quarter
+288 000 USD
Last Quarter
+178 569 USD
Current Year
+4 315 000 USD
Last Year
-1 603 000 USD
Current Quarter
-38 640 000 USD
Last Quarter
-1 678 555 USD
Key Figures PRTC
1 year
3 years
5 years
10 years
EBITDA
-132 524 000 USD
Operating Margin TTM
Price to Earnings
8.36
Return On Assets TTM
-13.12 %
PEG Ratio
–
Return On Equity TTM
6.42 %
Wall Street Target Price
53.25 USD
Revenue TTM
4 828 000 USD
Book Value
1.73 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
2 422.20 %
Dividend Yield
–
Gross Profit TTM
4 828 000 USD
Earnings per share
2.10 USD
Diluted Eps TTM
2.10 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
61.50 %
Profit Margin
1 108.33 %
Dividend Analytics PRTC
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History PRTC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio TTM
–
Last Split Date
–
Stock Valuation PRTC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
8.36
Forward PE
–
Enterprise Value Revenue
16.26
Price Sales TTM
88.75
Enterprise Value EBITDA
1.88
Price Book MRQ
1.03
Financials PRTC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PRTC
For 52 weeks
13.30 USD
32.98 USD
50 Day MA
17.48 USD
Shares Short Prior Month
9 715
200 Day MA
19.83 USD
Short Ratio
1.05
Shares Short
10 931
Short Percent
0.070 %
BeatStart